Global Flu Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Flu Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Flu Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Flu Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Flu Vaccine Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Flu Vaccine Sales by Type

2.3.1 Global Flu Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Flu Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Flu Vaccine Sale Price by Type (2017-2022)

2.4 Flu Vaccine Segment by Application

2.4.1 For Children (6 months to 3 years)

2.4.2 For Adults and Children over 3 years

2.5 Flu Vaccine Sales by Application

2.5.1 Global Flu Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Flu Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Flu Vaccine Sale Price by Application (2017-2022)

3 Global Flu Vaccine by Company

3.1 Global Flu Vaccine Breakdown Data by Company

3.1.1 Global Flu Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Flu Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Flu Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Flu Vaccine Revenue by Company (2020-2022)

3.2.2 Global Flu Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Flu Vaccine Sale Price by Company

3.4 Key Manufacturers Flu Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Flu Vaccine Product Location Distribution

3.4.2 Players Flu Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Flu Vaccine by Geographic Region

4.1 World Historic Flu Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Flu Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Flu Vaccine Annual Revenue by Geographic Region

4.2 World Historic Flu Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Flu Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Flu Vaccine Annual Revenue by Country/Region

4.3 Americas Flu Vaccine Sales Growth

4.4 APAC Flu Vaccine Sales Growth

4.5 Europe Flu Vaccine Sales Growth

4.6 Middle East & Africa Flu Vaccine Sales Growth

5 Americas

5.1 Americas Flu Vaccine Sales by Country

5.1.1 Americas Flu Vaccine Sales by Country (2017-2022)

5.1.2 Americas Flu Vaccine Revenue by Country (2017-2022)

5.2 Americas Flu Vaccine Sales by Type

5.3 Americas Flu Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Flu Vaccine Sales by Region

6.1.1 APAC Flu Vaccine Sales by Region (2017-2022)

6.1.2 APAC Flu Vaccine Revenue by Region (2017-2022)

6.2 APAC Flu Vaccine Sales by Type

6.3 APAC Flu Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Flu Vaccine by Country

7.1.1 Europe Flu Vaccine Sales by Country (2017-2022)

7.1.2 Europe Flu Vaccine Revenue by Country (2017-2022)

7.2 Europe Flu Vaccine Sales by Type

7.3 Europe Flu Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Flu Vaccine by Country

8.1.1 Middle East & Africa Flu Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Flu Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Flu Vaccine Sales by Type

8.3 Middle East & Africa Flu Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Flu Vaccine

10.3 Manufacturing Process Analysis of Flu Vaccine

10.4 Industry Chain Structure of Flu Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Flu Vaccine Distributors

11.3 Flu Vaccine Customer

12 World Forecast Review for Flu Vaccine by Geographic Region

12.1 Global Flu Vaccine Market Size Forecast by Region

12.1.1 Global Flu Vaccine Forecast by Region (2023-2028)

12.1.2 Global Flu Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Flu Vaccine Forecast by Type

12.7 Global Flu Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur

13.1.1 Sanofi Pasteur Company Information

13.1.2 Sanofi Pasteur Flu Vaccine Product Offered

13.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Main Business Overview

13.1.5 Sanofi Pasteur Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Flu Vaccine Product Offered

13.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Flu Vaccine Product Offered

13.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Flu Vaccine Product Offered

13.4.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

13.5 Hulan Bio

13.5.1 Hulan Bio Company Information

13.5.2 Hulan Bio Flu Vaccine Product Offered

13.5.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hulan Bio Main Business Overview

13.5.5 Hulan Bio Latest Developments

13.6 AstraZeneca

13.6.1 AstraZeneca Company Information

13.6.2 AstraZeneca Flu Vaccine Product Offered

13.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AstraZeneca Main Business Overview

13.6.5 AstraZeneca Latest Developments

13.7 CCBIO

13.7.1 CCBIO Company Information

13.7.2 CCBIO Flu Vaccine Product Offered

13.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 CCBIO Main Business Overview

13.7.5 CCBIO Latest Developments

14 Research Findings and Conclusion

Table 1. Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Trivalent Influenza Vaccine

Table 4. Major Players of Quadrivalent Influenza Vaccine

Table 5. Global Flu Vaccine Sales by Type (2017-2022) & (M Doses)

Table 6. Global Flu Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Flu Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Flu Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Flu Vaccine Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Flu Vaccine Sales by Application (2017-2022) & (M Doses)

Table 11. Global Flu Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Flu Vaccine Revenue by Application (2017-2022)

Table 13. Global Flu Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Flu Vaccine Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Flu Vaccine Sales by Company (2020-2022) & (M Doses)

Table 16. Global Flu Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Flu Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Flu Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Flu Vaccine Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Flu Vaccine Producing Area Distribution and Sales Area

Table 21. Players Flu Vaccine Products Offered

Table 22. Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Flu Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Flu Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Flu Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Flu Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Flu Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Flu Vaccine Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Flu Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Flu Vaccine Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Flu Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Flu Vaccine Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Flu Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Flu Vaccine Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Flu Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Flu Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Flu Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Flu Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Flu Vaccine Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Flu Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Flu Vaccine Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Flu Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Flu Vaccine Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Flu Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Flu Vaccine Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Flu Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Flu Vaccine Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Flu Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Flu Vaccine Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Flu Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Flu Vaccine Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Flu Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Flu Vaccine

Table 66. Key Market Challenges & Risks of Flu Vaccine

Table 67. Key Industry Trends of Flu Vaccine

Table 68. Flu Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Flu Vaccine Distributors List

Table 71. Flu Vaccine Customer List

Table 72. Global Flu Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Flu Vaccine Sales Market Forecast by Region

Table 74. Global Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Flu Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Flu Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Flu Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Flu Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Flu Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Flu Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Flu Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Flu Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Pasteur Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Pasteur Flu Vaccine Product Offered

Table 94. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. Sanofi Pasteur Main Business

Table 96. Sanofi Pasteur Latest Developments

Table 97. CSL Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. CSL Flu Vaccine Product Offered

Table 99. CSL Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. CSL Main Business

Table 101. CSL Latest Developments

Table 102. GSK Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. GSK Flu Vaccine Product Offered

Table 104. GSK Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. GSK Main Business

Table 106. GSK Latest Developments

Table 107. Mylan Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Mylan Flu Vaccine Product Offered

Table 109. Mylan Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 110. Mylan Main Business

Table 111. Mylan Latest Developments

Table 112. Hulan Bio Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Hulan Bio Flu Vaccine Product Offered

Table 114. Hulan Bio Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 115. Hulan Bio Main Business

Table 116. Hulan Bio Latest Developments

Table 117. AstraZeneca Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. AstraZeneca Flu Vaccine Product Offered

Table 119. AstraZeneca Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 120. AstraZeneca Main Business

Table 121. AstraZeneca Latest Developments

Table 122. CCBIO Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. CCBIO Flu Vaccine Product Offered

Table 124. CCBIO Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 125. CCBIO Main Business

Table 126. CCBIO Latest Developments

List of Figures

Figure 1. Picture of Flu Vaccine

Figure 2. Flu Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Flu Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Flu Vaccine Sales Market Share by Type in 2021

Figure 12. Global Flu Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Flu Vaccine Consumed in For Children (6 months to 3 years)

Figure 14. Global Flu Vaccine Market: For Children (6 months to 3 years) (2017-2022) & (M Doses)

Figure 15. Flu Vaccine Consumed in For Adults and Children over 3 years

Figure 16. Global Flu Vaccine Market: For Adults and Children over 3 years (2017-2022) & (M Doses)

Figure 17. Global Flu Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Flu Vaccine Revenue Market Share by Application in 2021

Figure 19. Flu Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Flu Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Flu Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Flu Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Flu Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Flu Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Flu Vaccine Sales 2017-2022 (M Doses)

Figure 26. Americas Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Flu Vaccine Sales 2017-2022 (M Doses)

Figure 28. APAC Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Flu Vaccine Sales 2017-2022 (M Doses)

Figure 30. Europe Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Flu Vaccine Sales 2017-2022 (M Doses)

Figure 32. Middle East & Africa Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Flu Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Flu Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Flu Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Flu Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Flu Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Flu Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Flu Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Flu Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Flu Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Flu Vaccine

Figure 63. Industry Chain Structure of Flu Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles